Pfizer Inc. (NYSE:PFE) reported that an experiment indicated its lung-cancer medicine Xalkori appreciably enhanced progression-free […]
Pfizer Inc. (NYSE:PFE) reported that an experiment indicated its lung-cancer medicine Xalkori appreciably enhanced progression-free […]